I personally think medical device firms offer just as much potential as biotech/drug companies, Given their medical devices are not easily imitated by other competitors.
The great thing about drug/biotech firms is that their technology/patents are protected and not easily copied. But, I like that CMP's leading position in sleep/neuro diagnostic and continuous R&D offers reasonable amount of hedges against imitators/competitors.
Intra-day trading shows signs of short-term profit trading. While it might drive down the share price temporarily, I think the good thing is that as more short term traders join, the stock becomes more liquid with larger trading volume and "potentially" generate more interests from stock brokers/institutional investors. It would be interesting to see the difference between short term and long term profit from CMP.
Pick your side! Good Luck
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)